Buy Carlyle

Logo for stock CG (Carlyle)

Amount

£
GBP

Latest price

$63.76
(£1.00 = $1.346)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$23.661B

P/E ratio

36.77

EPS

$1.785

Beta

2.05

Dividend rate

$1.40

Dividend yield

2.13%

About

The Carlyle Group Inc. is a global investment company. The Company's segments include Global Private Equity, Global Credit and Carlyle AlpInvest. The Global Private Equity segment advises the Company's buyout, growth, real estate, infrastructure, and natural resources funds. The segment also includes the NGP Carry Funds advised by NGP Energy Capital Management (NGP). The Global Credit segment advises funds and vehicles that pursue investment strategies including insurance solutions, liquid credit, opportunistic credit, direct lending, asset-backed finance, aviation finance, infrastructure credit, cross-platform credit products, and global capital markets. The Carlyle AlpInvest segment advises global private equity programs that pursue secondary purchases and financing of existing portfolios, managed co-investment programs, and primary fund investments. The Carlyle AlpInvest segment helps investors meet their objectives through tailored portfolio construction and investment selection.

CEO

Mr. Harvey M. Schwartz

Employees

2,300

Sector

Finance

Company HQ

WASHINGTON, United States of America

News

Logo for news article #0 (Abingworth Announces Leadership Transition and Appointments)

Abingworth Announces Leadership Transition and Appointments

Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ: CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning to Managing Partner of Abingworth.

GlobeNewsWire

January 05, 2026

Logo for news article #1 (Bank of America turns bullish on alternatives as private credit, e-trading and crypto heat up)

Bank of America turns bullish on alternatives as private credit, e-trading and crypto heat up

Bank of America analysts are signaling growing optimism for the alternatives space in 2026, with private credit, fixed income e-trading, and crypto as key to driving investor interest. In a January update to its 2026 industry outlook for brokers, asset managers, and exchanges, the bank said it is “more bullish on alternatives” compared with online brokers, citing stronger macro conditions and a more favorable valuation setup.

Proactive Investors

January 02, 2026

Logo for news article #2 (Picus Capital Announces Close of €150M Preferred Equity Financing from Carlyle AlpInvest)

Picus Capital Announces Close of €150M Preferred Equity Financing from Carlyle AlpInvest

MUNICH--(BUSINESS WIRE)--Picus Capital (“Picus” or the “Firm”), a global venture capital firm, today announced the closing of a €150 million preferred equity financing transaction provided by Carlyle AlpInvest, a leading global private markets manager. The transaction provides Picus with significant capital for new investments and supports the continued growth of its existing portfolio of almost 200 companies, including notable investments such as Personio and Enpal. Founded in 2015 as a privat.

Business Wire

December 18, 2025

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2026 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies is an Introducer Appointed Representative of Quint Group Limited and not a lender. Quint Group Limited is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 669450). Monevo Limited is an Appointed Representative of TransUnion International UK Limited. TransUnion is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 737740). Emma Technologies introduces customers first to Quint Group Limited, as a licensed credit broker, who then refers on to Monevo Limited.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.